SF3A3 and neoplasm: Consistent with the in vitro results, we found that SF3A3 supplementation successfully reversed the tumor-suppressing function of circSCAP overexpression, as displayed by the tumor volume (Fig. 7C upper and Figure S8A) and tumor weight (Fig. 7C lower) alteration.